Literature DB >> 19901962

C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.

J Zhang1, M Gonit, M D Salazar, A Shatnawi, L Shemshedini, R Trumbly, M Ratnam.   

Abstract

Nuclear expression of CCAAT enhancer binding protein-alpha (C/EBPalpha), which supports tissue differentiation through several antiproliferative protein-protein interactions, augurs terminal differentiation of prostate epithelial cells. C/EBPalpha is also a tumor suppressor, but in many tumors its antiproliferative interactions may be attenuated by de-phosphorylation. C/EBPalpha acts as a corepressor of the classical androgen response element (ARE)-mediated gene activation by the androgen receptor (AR), but this is paradoxical as the genotropic actions of AR are crucial not only for the growth of the prostate but also for its maintenance and function. We show that DNA-bound C/EPBalpha recruits AR to activate transcription. C/EBPalpha-dependent trans-activation by AR also overrode suppression of AREs by C/EBPalpha elsewhere in a promoter. This mechanism was remarkable in that its androgen dependence was apparently for nuclear translocation of AR; it was otherwise androgen independent, flutamide insensitive and tolerant to disruption of AR dimerization. Gene response profiles and global chromatin associations in situ supported the direct bimodal regulation of AR transcriptional signaling by C/EBPalpha. This unique mechanism explains the functional coordination between AR and C/EPBalpha in the prostate and also shows that hormone-refractory AR signaling in prostate cancer could occur through receptor tethering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901962      PMCID: PMC3836216          DOI: 10.1038/onc.2009.373

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

Review 1.  Nuclear receptor-mediated transactivation through interaction with Sp proteins.

Authors:  Stephen Safe; Kyounghyun Kim
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

Review 2.  Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain.

Authors:  I J McEwan
Journal:  Endocr Relat Cancer       Date:  2004-06       Impact factor: 5.678

3.  Trawler: de novo regulatory motif discovery pipeline for chromatin immunoprecipitation.

Authors:  Laurence Ettwiller; Benedict Paten; Mirana Ramialison; Ewan Birney; Joachim Wittbrodt
Journal:  Nat Methods       Date:  2007-06-24       Impact factor: 28.547

4.  R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.

Authors:  Aymen Shatnawi; Thuyet Tran; Manohar Ratnam
Journal:  Mol Endocrinol       Date:  2006-12-27

Review 5.  Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?

Authors:  ShouWei Han; Jesse Roman
Journal:  Anticancer Drugs       Date:  2007-03       Impact factor: 2.248

6.  The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.

Authors:  Christine Müller; Cornelis F Calkhoven; Xiaojing Sha; Achim Leutz
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

7.  Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells.

Authors:  Silvère Baron; Michèle Manin; Claude Beaudoin; Laurent Leotoing; Yves Communal; Georges Veyssiere; Laurent Morel
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

8.  Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.

Authors:  Guo-Li Wang; Polina Iakova; Margie Wilde; Samir Awad; Nikolai A Timchenko
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

9.  Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis.

Authors:  Kari D Loomis; Songyun Zhu; Kyungsil Yoon; Peter F Johnson; Robert C Smart
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Structural basis of androgen receptor binding to selective androgen response elements.

Authors:  Paul L Shaffer; Arif Jivan; D Eric Dollins; Frank Claessens; Daniel T Gewirth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

View more
  16 in total

Review 1.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Androgen activation of the folate receptor α gene through partial tethering of the androgen receptor by C/EBPα.

Authors:  Suneethi Sivakumaran; Juan Zhang; Karen M M Kelley; Mesfin Gonit; Hong Hao; Manohar Ratnam
Journal:  J Steroid Biochem Mol Biol       Date:  2010-09-15       Impact factor: 4.292

3.  Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder.

Authors:  Arezou Sayad; Rezvan Noroozi; Mir Davood Omrani; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2017-06-12       Impact factor: 3.584

4.  Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.

Authors:  Mesfin Gonit; Juan Zhang; Marcela d'Alincourt Salazar; Hongjuan Cui; Aymen Shatnawi; Robert Trumbly; Manohar Ratnam
Journal:  Mol Endocrinol       Date:  2011-02-17

5.  The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.

Authors:  Mugdha Patki; Venkatesh Chari; Suneethi Sivakumaran; Mesfin Gonit; Robert Trumbly; Manohar Ratnam
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

6.  Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.

Authors:  Rayna Rosati; Lisa Polin; Charles Ducker; Jing Li; Xun Bao; Dakshnamurthy Selvakumar; Seongho Kim; Besa Xhabija; Martha Larsen; Thomas McFall; Yanfang Huang; Benjamin L Kidder; Andrew Fribley; Janice Saxton; Hiroki Kakuta; Peter Shaw; Manohar Ratnam
Journal:  Clin Cancer Res       Date:  2018-09-05       Impact factor: 12.531

7.  Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors.

Authors:  David P Labbé; Dawid G Nowak; Geneviève Deblois; Laurent Lessard; Vincent Giguère; Lloyd C Trotman; Michel L Tremblay
Journal:  Mol Cancer Res       Date:  2013-12-30       Impact factor: 5.852

8.  The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.

Authors:  Karyn Schmidt; Cailin E Joyce; Frank Buquicchio; Adam Brown; Justin Ritz; Robert J Distel; Charles H Yoon; Carl D Novina
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

9.  CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.

Authors:  D J Barakat; J Zhang; T Barberi; S R Denmeade; A D Friedman; I Paz-Priel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

10.  Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.

Authors:  Carly J King; Josha Woodward; Jacob Schwartzman; Daniel J Coleman; Robert Lisac; Nicholas J Wang; Kathryn Van Hook; Lina Gao; Joshua Urrutia; Mark A Dane; Laura M Heiser; Joshi J Alumkal
Journal:  Oncotarget       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.